CRYSTAL FORM OF FGFR4 SELECTIVE INHIBITOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

The present invention relates to a crystal form A of a compound of formula (I), and a preparation method therefor and the use thereof. The crystal form A has good properties in terms of physical and chemical stability, water solubility, bioavailability and processing adaptability. La présente invent...

Full description

Saved in:
Bibliographic Details
Main Authors ZHENG, Jianfeng, SHI, Zhenjuan, SU, Di, GONG, Yongxiang, ZHONG, Jinqing
Format Patent
LanguageChinese
English
French
Published 19.10.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a crystal form A of a compound of formula (I), and a preparation method therefor and the use thereof. The crystal form A has good properties in terms of physical and chemical stability, water solubility, bioavailability and processing adaptability. La présente invention concerne en particulier une forme cristalline A d'un composé de formule (I), son procédé de préparation et son utilisation. La forme cristalline A présente de bonnes propriétés en termes de stabilité physique et chimique, d'hydrosolubilité, de biodisponibilité et d'adaptabilité au traitement. 本发明涉及式(I)化合物的晶型A以及其制备方法和用途。所述晶型A在物理化学稳定性、水溶性、生物利用度和加工适应性方面均具有优异的性质。
Bibliography:Application Number: WO2023CN87201